• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China

tetano

Editor, Senior Moderator
J Zhejiang Univ Sci B. 2012 Jan;13(1):49-55.
Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China.
Deng LH, Zeng YL, Feng P, Liu YL, Wang LC, Bai Y, Tang H.
Source

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China; Division of Infectious Diseases, State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China; Chengdu Infectious Disease Hospital, Chengdu 610041, China.
Abstract

Objective: The critical illness of pandemic influenza A (H1N1) virus infection may be associated with relatively poor outcomes. The objective of this study is to describe clinical features and factors associated with the deaths of critical patients. Methods: Medical records of 26 critical patients with H1N1 infection admitted from Sept. 1 to Dec. 31, 2009, were retrospectively reviewed. Diagnosis was established by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay. Results: The mean age of the patients was (40.4?18.4) years and 73.1% of them were male. Clinical manifestations included fever, cough, and sputum production. The laboratory findings included leukocytosis, lymphopenia, C-reaction protein, and lactic dehydrogenase elevation. In this series, 17 subjects survived and 9 died. The parameters between the deaths and survivors were compared, which included acute physiology and chronic health evaluation II (APACHE II) scores (23.8?10.1 vs. 14.3?6.6, P<0.05), sequential organ failure assessment (SOFA) scores (13.3?3.0 vs. 6.6?3.3, P<0.05), and multiple organ dysfunction syndrome (MODS) scores (7.4?2.5 vs. 3.3?1.7, P<0.05). The cases of deaths had higher incidences of cardiovascular failure (100% vs. 41.2%, P<0.05), renal failure (55.6% vs. 11.7%, P<0.05), encephalopathy (44.4% vs. 5.9%, P<0.05), hepatic failure (33.3% vs. 5.9%, P<0.05), and septic shock (33.3% vs. 17.6%, P<0.05). Conclusions: The critical patients with H1N1 infection have high APACHE II, SOFA, and MODS scores, which may be associated with an increased risk of death and complex clinical courses.

PMID:
22205620
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/22205620
 
Back
Top Bottom